Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Journal of Anhui Health Vocational & Technical College》 2007-06
Add to Favorite Get Latest Update

Clinical application of rhG-CSF in chemotherapy for solid tumors

1Department of Oncology, Central Hospital of China TIESIJU Civil Engineering Group CO.LTD, Heifei 230022; 2Dept of Oncology, the Affiliated Provincial Hospital of Anhui Medical University, Heifei 230001ZHAO Wen-jie1, WANG Yong2, HU Chang-lu2  
Objective To investigate the proper interval between chemotherapy for solid tumors and recombinant human granulocyte colony stimulating factor(rhG-CSF) administration.Methods Thirty patients who received chemotherapy and rhG-CSF injection were randomly divided into two groups,15 patients in group A were given rhG-CSF 24 hours after chemotherapy, another 15 patients in Group B were given rhG-CSF only when the white blood cell counts (WBC) dropped to 2×109/L. Results Both could effectively prevent bone marrow depression and fulfill the treatment, but the average amount of the drug in group B was 3.69 compared with 6.17 in group A, which showed statistically difference between them(P0.01). Conclusion Different applications of rhG-CSF have almost the same efficacy, while showing statistical difference in economics, which needs further study.
【CateGory Index】: R730.5
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved